GO Therapeutics

GO Therapeutics

Biotechnology Research Natick, Massachusetts, United States 9 employees
Employees
9
Contacts
3
Emails
3
Phones
3

GO Therapeutics Overview

Headquarters
Natick, Massachusetts, United States
Industry
Biotechnology Research
Employees
9
Founded
2014
Funding
5.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About GO Therapeutics

GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.

GO Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

GO Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Robert Wills Chairman of the Board of Milestone
Email Phone
Boris Klebanov
Email Phone
Vikas Sharma Chief Business Officer @ Quralis
View
Samuel Murphy Chief Executive Officer at Salubris
Email Phone

Employees by Management Level

Executive 2 profiles
Individual contributor 1 profile

Compare Similar Companies to GO Therapeutics